Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
Hepatic fibrosis is often secondary to chronic inflammatory liver injury. During the development of hepatic fibrosis, the damaged hepatocytes and activated hepatic stellate cells (HSCs) caused by the pathogenic injury could secrete a variety of cytokines and chemokines, which will chemotactic innate...
Main Authors: | Nana Zhang, Huimin Yao, Zhixuan Zhang, Zhuoqun Li, Xue Chen, Yan Zhao, Ran Ju, Jiayi He, Heli Pan, Xiaoli Liu, Yi Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1131588/full |
Similar Items
-
New Drugs for Hepatic Fibrosis
by: Liang Shan, et al.
Published: (2022-06-01) -
Curcumin- and Cyclopamine-Loaded Liposomes to Enhance Therapeutic Efficacy Against Hepatic Fibrosis
by: Zhang T, et al.
Published: (2020-12-01) -
The Ultrastructure of Hepatic Stellate Cell–Macrophage Intercellular Crosstalk as a New Morphological Insight into Phenomenon of Fibrogenesis in Pediatric Autoimmune Hepatitis
by: Joanna Maria Łotowska, et al.
Published: (2023-01-01) -
The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice
by: Xi Li, et al.
Published: (2018-02-01) -
Kupffer Cells: Important Participant of Hepatic Alveolar Echinococcosis
by: Yumei Liu, et al.
Published: (2020-01-01)